View More Recent Stories

Mar 18, 2025 06:30AM COMPASS Pathways plc (CMPS) Announces Publication of Results from COMP004 Study on COMP360 Psilocybin
Mar 5, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on Compass Pathways (CMPS)
Feb 28, 2025 06:54AM Compass Pathways (CMPS) PT Lowered to $15 at Canaccord Genuity
Feb 27, 2025 06:32AM COMPASS Pathways plc (CMPS) Reports In-Line Q4 EPS
Feb 26, 2025 04:06PM Stifel Starts Compass Pathways (CMPS) at Buy
Feb 13, 2025 06:49AM Compass Pathways (CMPS) PT Lowered to $45 at H.C. Wainwright
Jan 29, 2025 09:12AM Cantor Fitzgerald provides update on Biotechnology stocks
Jan 27, 2025 06:58AM Compass Pathways (CMPS) PT Lowered to $9 at Rodman & Renshaw
Jan 21, 2025 06:32AM COMPASS Pathways plc (CMPS) Appoints Steve Levine as Chief Patient Officer
Jan 10, 2025 07:03AM COMPASS Pathways plc (CMPS) prices 24M ADS at $5.796
Dec 18, 2024 06:30AM COMPASS Pathways plc (CMPS) to Join NASDAQ Biotechnology Index (NBI)
Nov 11, 2024 07:13AM Compass Pathways (CMPS) PT Lowered to $23 at Canaccord Genuity
Nov 4, 2024 06:47AM Compass Pathways (CMPS) PT Lowered to $60 at H.C. Wainwright
Nov 1, 2024 06:20AM Compass Pathways (CMPS) PT Lowered to $18 at RBC Capital
Oct 31, 2024 06:36AM COMPASS Pathways plc (CMPS) Tops Q3 EPS by 1c
Aug 13, 2024 09:41AM TD Cowen Reiterates Buy Rating on Compass Pathways (CMPS)
Aug 2, 2024 09:15AM Compass Pathways (CMPS) PT Lowered to $48 at Canaccord Genuity
Aug 1, 2024 08:44AM COMPASS Pathways plc (CMPS) Misses Q2 EPS by 3c
Jul 23, 2024 03:16AM RBC Capital Starts Compass Pathways (CMPS) at Outperform
Jul 22, 2024 04:24PM RBC Capital Starts Compass Pathways (CMPS) at Outperform
Jun 26, 2024 06:31AM COMPASS Pathways plc (CMPS) Appoints Lori Englebert as Chief Commercial Officer
View More Recent Stories